Evidence map›Paper›PMID 35889064›Full record

ReviewMicroorganisms2022

Nontuberculous Mycobacteria as Sapronoses: A Review.

Ivo Pavlik, Vit Ulmann, Dana Hubelova, Ross Tim Weston

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Prevalence ofFrontiers in microbiology · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Spatiotemporal distribution ofEmerging microbes & infections · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Evidence ofFrontiers in veterinary science · 2025
    Article
  12. Four novel nontuberculous mycobacteria species:International journal of systematic and evolutionary microbiology · 2025
    Article
  13. Swollen Necrotic Lymphadenitis Infected withInfection and drug resistance · 2024
    Article
  14. Article
  15. Article
  16. A Rare Case of Osteomyelitis of an Ankle Caused byAntibiotics (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Isolation ofFrontiers in veterinary science · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ivo PavlikFaculty of Regional Development and International Studies, Mendel University in Brno, Tr. Generala Piky 7, 613 00 Brno, Czech Republic.ORCID 0000-0002-5771-3381
Vit UlmannPublic Health Institute Ostrava, Partyzanske Nam. 7, 702 00 Ostrava, Czech Republic.ORCID 0000-0002-5203-8276
Dana HubelovaFaculty of Regional Development and International Studies, Mendel University in Brno, Tr. Generala Piky 7, 613 00 Brno, Czech Republic.ORCID 0000-0002-2551-8792
Ross Tim WestonDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Science Dr, Bundoora, Melbourne, VIC 3086, Australia.
Mendel University in Brno · CZLa Trobe University · AUPublic Health Institute Ostrava · CZ

Funding

Czech Health Research Council NU20-09-00114
6 · The paper itself

Abstract

Mycobacteria are a unique group of microorganisms. They are characterised by exceptional adaptability and durability. They are capable of colonisation and survival even in very unfavourable conditions. In addition to the well-known obligate human pathogens,

Indexed as

antidiarrhealearth-eatingenvironmental saprophytic mycobacteriafeeding and eating disordersgeochemistrygeophagiamudPICA practicespotentially pathogenic mycobacteriasaprophytic mycobacteriasaprozoic mycobacteriasoil consumptionsoil exposuretrace elements deficiency

Identifiers

PMID35889064
PMCPMC9315685
OpenAlexW4283790365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.